Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS

Kidney International

Volumn 63, Issue 6, 2003, Pages 2222-2229

  Burdick, Rachel A ^a   Bragg Gresham, Jennifer L ^b   Woods, John D ^b   Hedderwick, Sara A ^b   Kurokawa, Kiyoshi ^b   Combe, Christian ^b   Saito, Akira ^b   LaBrecque, John ^b   Port, Friedrich K ^b   Young, Eric W ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

Dialysis Outcomes and Practice Patterns Study; Hepatitis B; Infection control protocols; Seroconversion; Vaccine

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; CLINICAL PRACTICE; FEMALE; FRANCE; GERMANY; HEALTH CARE FACILITY; HEMODIALYSIS; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; SEROCONVERSION; SEROPREVALENCE; SPAIN; UNITED KINGDOM; UNITED STATES; VACCINATION;

EID: 0037850873     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00017.x     Document Type: Article

References (41)

1. LOK A: Chronic hepatitis B. N Engl J Med 346:1682-1683, 2002
2. FABRIZI F, LUNGHI G, MARTIN P, POORDAD FF: Serological and molecular testing in hepatitis B and the dialysis patient. Int Artif Organs 25:91-99, 2002
3. LONDON WT, DREW JS, LUSTBADER ED, et al: Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. Kidney Int 12:51-58, 1977
4. RIBOT S, ROTHSTEIN M, GOLDBLAT M, GRASSO M: Duration of hepatitis B surface antigenemia (HbsAg) in hemodialysis patients. Arch Intern Med 139:178-180, 1979
5. CHAREST A, MCDOUGALL J, GOLDSTEIN M: A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36:976-982, 2000
6. KOHLER H, ARNOLD W, RENSCHIN G, et al: Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124-128, 1984
7. STEKETEE RW, ZIARNIK ME, DAVIS JP: Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 127:772-782, 1988
8. STEPHENNE J: Recombinant vs. plasma-derived hepatitis B vaccines: Issues of safety, immunogenicity and cost-effectiveness. Vaccine 6:299-303, 1988
9. BRUGUERA M, RODICIO JL, ALCAZAR JM, et al: Effects of different dose levels and vaccination schedules on immune response to recombinant DNA hepatitis B vaccine in hemodialysis patients. Vaccine 8:S47-S52, 1990
10. ALBERTONI F, BATTILOMO A, DINARDO V, et al: Evaluation of a region-wide hepatitis B vaccination program in dialysis patients: Experience in an Italian region. The Latium Hepatitis Prevention Group. Nephron 58:180-183, 1991
11. MARCELLI D, STANNARD D, CONTE F, et al: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) vs. the United States. Kidney Int 50:1013-1018, 1996
12. JHA R, KHER V, NAIK S, et al: Hepatitis B associated liver disease in dialysis patients: Role of vaccination. J Nephrol 6:98-103, 1993
13. MAISONNEUVE P, AGODOA L, GELLERT R, et al: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354:93-99, 1999
14. PARFREY PS, FARGE D, FORBES RD, et al: Chronic hepatitis in end-stage renal disease: Comparison of HbsAg-negative and HbsAg-positive patients. Kidney Int 28:959-967, 1985
15. PARFREY PS, FORBES RDD, HUTCHISON TA, et al: The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 39:610-612, 1985
16. KLEIM V, RINGE B, HOLHORST K, et al: Kidney transplantation in hepatitis B surface antigen carriers. Clin Invest 72:1000-1005, 1994
17. GREKAS D, DIONDIS C, MANDRAELIK K, et al: Renal transplantation in asymptomatic carriers of hepatitis B surface antigen. Nephron 69:267-271, 1995
18. MORALES JM: Renal transplantation in patients positive for hepatitis B or C. Transplant Proc 30:2064-2069, 1998
19. POL S, SAMUEL D, CADRANEL JF, et al: Hepatitis and solid organ transplanation. Transplant Proc 32:454-457, 2000
20. MATHURIN P, MOUQUET C, POYNARD T, et al: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29:257-263, 1999
21. SNYDMAN DR, BREGMAN D, RYAN JA: Hemodialysis-associated hepatitis in the United States, 1974. J Infect Dis 135:687-691, 1977
22. CENTERS FOR DISEASE CONTROL, in Control Measures for Hepatitis B in Dialysis Centers. Viral Hepatitis Investigations and Control Series, Atlanta, Centers for Disease Control and Prevention, 1977
23. TOKARS JI, MILLER ER, ALTER MJ, ARDUINO MJ, in National Surveillance of Dialysis-Associated Diseases in the United States, 1996, Atlanta, Centers for Disease Control and Prevention, 1998, pp 1-59
24. FABRIZI F, MARTIN P, LUNGHI G, PONTICELLI C: Novel evidence on hepatitis B virus infection in dialysis. Int J Artif Organs 24:8-16, 2001
25. TOKARS JI, ALTER MJ, FAVERO MS, et al: National surveillance of dialysis-associated diseases in the United States, 1993. ASAIO J 42:219-229, 1996
26. PETROSILLO N, PURO V, IPPOLOTO G, and the Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-borne Infections in Dialysis: Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. Nephron 64:636-639, 1993
27. UNITED STATES RENAL DATA SYSTEM, in USRDS 1994 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 1994
28. OGUCHI H, MIYASAKA M, TOKUNAGA S, et al: Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 38:36-43, 1992
29. COVIC A, IANCU L, APETREI C, et al: Hepatitis virus infection in hemodialysis patients from Moldavia. Nephrol Dial Transplant 14:40-45, 1999
30. VLADUTIU D, COSA A, NEAMTU A, et al: Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: Yellow spots on a blank map? J Viral Hepat 7:313-319, 2000
31. NETO MC, MANZANO SI, CANZIANI ME, et al: Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. int J Artif Organs 19:251-255, 1995
32. GUANYU W, NAN C, JIAQI Q, et al: Nephrology, dialysis and transplantation in Shanghai, 1999. Nephrol Dial Transplant 15:961-963, 2000
33. YOUNG EW, GOODKIN DA, MAPES DL, et al: The dialysis outcomes and practice patterns study: An international hemodialysis study. Kidney Int 57(Suppl 74):S74-S81, 2000
34. SAS/STAT USER'S GUIDE, in Version 8, Cary, NC, SAS Institute, p 1452
35. KLEIN J, MOESCHBERGER M, in Survival Analysis Techniques for Censored and Truncated Data, New York, Springer, 1997, pp 416-418
36. PUBLIC HEALTH LABORATORY SERVICE SURVEY: Decrease in the incidence of hepatitis on dialysis units associated with prevention programme. Br Med J 4:751-754, 1974
37. MARMION BP, BURRELL CJ, TONKIN RW, DICKSON J: Dialysis-associated hepatitis in Edinburgh: 1969-1978. Rev Infect Dis 4:619-637, 1982
38. RECOMMENDATIONS MMWR AND REPORTS, in Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients, April 27, 2001/50(RR05), pp 1-43, available at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005al.htm
39. CENTERS FOR DISEASE CONTROL AND PREVENTION: Outbreaks of hepatitis B virus infection among hemodialysis patients - California, Nebraska, and Texas, 1994. JAMA 275:1394-1395, 1996
40. FAVERO MS, DEANE N, LEGER RT, SOSIN AE: Effect of multiple use of dialyzers on hepatitis B incidence in patients and staff. JAMA 245:166-167, 1981
41. ALTER MJ, FAVERO MS, MILLER JK, et al: Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects. JAMA 26: 2073-2076, 1988